Current Articles | RSS Feed
Biosearch Technologies today announces the company has licensed exclusively from the University of Medicine and Dentistry of New Jersey (UMDNJ) a Single Molecule Fluorescent in-situ hybridization technology based on detection of RNA. Biosearch owns the exclusive rights to manufacture, catalogue and sell validated RNA FISH probes, assays and kits into the Research, Applied Markets and IVD fields under the UMDNJ technologies and patent applications.
To read the entire story, read the full press release.
Biosearch Technologies announced today that it has been awarded new patents related to luminescent metal chelate and novel enzymatic reporter system. These patents demonstrate Biosearch's continued advancement in the field of pro-fluorescent assays.